Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications

Overview

Journal Immune Netw

Specialty Allergy & Immunology

Date 2024 May 10

PMID 38725675

Authors

Shuanglong Zhou

Jialing Huang

Yi Zhang

Hongsong Yu

Xin Wang

Affiliations

Soon will be listed here.

Abstract

Exosomes are double phospholipid membrane vesicles that are synthesized and secreted by a variety of cells, including T cells, B cells, dendritic cells, immune cells, are extracellular vesicles. Recent studies have revealed that exosomes can play a significant role in under both physiological and pathological conditions. They have been implicated in regulation of inflammatory responses, immune response, angiogenesis, tissue repair, and antioxidant activities, particularly in modulating immunity in autoimmune diseases (AIDs). Moreover, variations in the expression of exosome-related substances, such as miRNA and proteins, may not only offer valuable perspectives for the early warning, and prognostic assessment of various AIDs, but may also serve as novel markers for disease diagnosis. This article examines the impact of exosomes on the development of AIDs and explores their potential for therapeutic application.

References

Wang L, Wang C, Jia X, Yu J . Circulating Exosomal miR-17 Inhibits the Induction of Regulatory T Cells via Suppressing TGFBR II Expression in Rheumatoid Arthritis. Cell Physiol Biochem. 2018; 50(5):1754-1763. DOI: 10.1159/000494793. View

Pang H, Fan W, Shi X, Li J, Wang Y, Luo S . Characterization of lncRNA Profiles of Plasma-Derived Exosomes From Type 1 Diabetes Mellitus. Front Endocrinol (Lausanne). 2022; 13:822221. PMC: 9135040. DOI: 10.3389/fendo.2022.822221. View

Xu H, Bao Z, Liang D, Li M, Wei M, Ge X . Plasma exosomal miR-106a-5p expression in myasthenia gravis. Muscle Nerve. 2020; 61(3):401-407. DOI: 10.1002/mus.26785. View

Ren Z, Liu X, Abdollahi E, Tavasolian F . Genetically Engineered Exosomes as a Potential Regulator of Th1 Cells Response in Rheumatoid Arthritis. Biopreserv Biobank. 2023; 21(4):355-366. DOI: 10.1089/bio.2022.0003. View

Yin W, Ouyang S, Luo Z, Zeng Q, Hu B, Xu L . Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis. Inflammation. 2017; 40(4):1460-1473. DOI: 10.1007/s10753-017-0589-2. View

Li Z, Wang Y, Xiao K, Xiang S, Li Z, Weng X . Emerging Role of Exosomes in the Joint Diseases. Cell Physiol Biochem. 2018; 47(5):2008-2017. DOI: 10.1159/000491469. View

Hiratsuka I, Yamada H, Munetsuna E, Hashimoto S, Itoh M . Circulating MicroRNAs in Graves' Disease in Relation to Clinical Activity. Thyroid. 2016; 26(10):1431-1440. DOI: 10.1089/thy.2016.0062. View

Xiao Y, Tian J, Wu W, Gao Y, Guo Y, Song S . Targeting central nervous system extracellular vesicles enhanced triiodothyronine remyelination effect on experimental autoimmune encephalomyelitis. Bioact Mater. 2021; 9:373-384. PMC: 8586265. DOI: 10.1016/j.bioactmat.2021.07.017. View

Fan J, Han Y, Sun H, Sun S, Wang Y, Guo R . Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2. Biomed Pharmacother. 2023; 162:114593. DOI: 10.1016/j.biopha.2023.114593. View

10.

Cui X, Liu Y, Wang S, Zhao N, Qin J, Li Y . Circulating Exosomes Activate Dendritic Cells and Induce Unbalanced CD4+ T Cell Differentiation in Hashimoto Thyroiditis. J Clin Endocrinol Metab. 2019; 104(10):4607-4618. DOI: 10.1210/jc.2019-00273. View

11.

Ridgewell D, Thalayasingam N, Ng W . Sjögren's syndrome: shedding light on emerging and key drug targets. Expert Opin Ther Targets. 2022; 26(10):869-882. DOI: 10.1080/14728222.2022.2157259. View

12.

Hu Q, Su H, Li J, Lyon C, Tang W, Wan M . Clinical applications of exosome membrane proteins. Precis Clin Med. 2020; 3(1):54-66. PMC: 7099650. DOI: 10.1093/pcmedi/pbaa007. View

13.

Tu J, Zheng N, Mao C, Liu S, Zhang H, Sun L . UC-BSCs Exosomes Regulate Th17/Treg Balance in Patients with Systemic Lupus Erythematosus via miR-19b/KLF13. Cells. 2022; 11(24). PMC: 9777319. DOI: 10.3390/cells11244123. View

14.

Xu H, Jia S, Xu H . Potential therapeutic applications of exosomes in different autoimmune diseases. Clin Immunol. 2019; 205:116-124. DOI: 10.1016/j.clim.2019.06.006. View

15.

Ma D, Wu Z, Zhao X, Zhu X, An Q, Wang Y . Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4 T cells in patients with primary Sjögren's syndrome. Inflammopharmacology. 2023; 31(4):1823-1838. PMC: 10352432. DOI: 10.1007/s10787-023-01189-x. View

16.

Andre F, Bockle B . Sjögren's syndrome. J Dtsch Dermatol Ges. 2022; 20(7):980-1002. PMC: 9539881. DOI: 10.1111/ddg.14823. View

17.

Zhang L, Qin Z, Sun H, Chen X, Dong J, Shen S . Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact Mater. 2022; 18:1-14. PMC: 8961303. DOI: 10.1016/j.bioactmat.2022.02.017. View

18.

Vargas-Uricoechea H . Molecular Mechanisms in Autoimmune Thyroid Disease. Cells. 2023; 12(6). PMC: 10047067. DOI: 10.3390/cells12060918. View

19.

Zhong H, Lu J, Jing S, Xi J, Yan C, Song J . Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients. J Neuroimmunol. 2020; 348:577383. DOI: 10.1016/j.jneuroim.2020.577383. View

20.

Zhang Y, Tu B, Sha Q, Qian J . Bone marrow mesenchymal stem cells-derived exosomes suppress miRNA-5189-3p to increase fibroblast-like synoviocyte apoptosis via the BATF2/JAK2/STAT3 signaling pathway. Bioengineered. 2022; 13(3):6767-6780. PMC: 8973596. DOI: 10.1080/21655979.2022.2045844. View